BOO KYUNG KIM: Open Payments
NPI 1285376749 · LONG ISLAND CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,122 in 177 payments from 18 companies in 2025. Trend: 2023 $490 · 2024 $2,068 · 2025 $6,122
Food & beverage: $5,972Education: $150
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 20 | $883 |
| Incyte Corporation | 25 | $774 |
| Galderma Laboratories, L.P. | 17 | $662 |
| ABBVIE INC. | 23 | $635 |
| Regeneron Healthcare Solutions, Inc. | 8 | $569 |
| UCB, Inc. | 15 | $516 |
| Arcutis Biotherapeutics, Inc. | 15 | $405 |
| Amgen Inc. | 5 | $346 |
| MAYNE PHARMA COMMERCIAL LLC | 13 | $344 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $290 |
Products named: DUPIXENT, OPZELURA, NEMLUVIO, Bimzelx, RINVOQ, Zoryve, OTEZLA, ADBRY.
Industry payments across NY — which companies pay providers there.
